Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 07, 2022 Filed Mar 9, 2022 01:04 UTC |
BEHRENS M KATHLEENDirector
|
GrantCommon Stock | 2,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017349 · doc4.xml · nonDerivative · entry 1 BEHRENS M KATHLEEN · CIK 0001211701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,470 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 7, 2023. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 01:02 UTC |
Brown Ryan EdwardSVP, General Counsel
|
GrantStock Option (right to buy) · Derivative | 48,000 | $0.00 Strike: $80.42 | $0.00 |
DisclosureSEC source: 0001209191-22-017346 · doc4.xml · derivative · entry 4 Brown Ryan Edward · CIK 0001848718 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Underlying: Common Stock · 48,000 shares Expires 2032-03-07 F4 · derivative.exercise_date: Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 01:02 UTC |
Brown Ryan EdwardSVP, General Counsel
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017346 · doc4.xml · nonDerivative · entry 3 Brown Ryan Edward · CIK 0001848718 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,895 F3 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 01:02 UTC |
Brown Ryan EdwardSVP, General Counsel
|
Tax withholdingCommon Stock | 153 | $79.36 | $12,142.08 |
DisclosureSEC source: 0001209191-22-017346 · doc4.xml · nonDerivative · entry 2 Brown Ryan Edward · CIK 0001848718 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,895 F2 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 4, 2019. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 01:03 UTC |
Barry RichardDirector
|
GrantStock Option (right to buy) · Derivative | 5,077 | $0.00 Strike: $80.42 | $0.00 |
DisclosureSEC source: 0001209191-22-017348 · doc4.xml · derivative · entry 3 Barry Richard · CIK 0001562371 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,077 Underlying: Common Stock · 5,077 shares Expires 2032-03-07 Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 01:03 UTC |
Barry RichardDirector
|
GrantCommon Stock | 2,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017348 · doc4.xml · nonDerivative · entry 1 Barry Richard · CIK 0001562371 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,928,319 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 7, 2023. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 01:02 UTC |
Estepan Ian MichaelChief Financial Officer
|
GrantStock Option (right to sell) · Derivative | 48,000 | $0.00 Strike: $80.42 | $0.00 |
DisclosureSEC source: 0001209191-22-017347 · doc4.xml · derivative · entry 4 Estepan Ian Michael · CIK 0001836254 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Underlying: Common Stock · 48,000 shares Expires 2032-03-07 F4 · derivative.exercise_date: Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 01:02 UTC |
Estepan Ian MichaelChief Financial Officer
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017347 · doc4.xml · nonDerivative · entry 3 Estepan Ian Michael · CIK 0001836254 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,671 F3 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 01:02 UTC |
Estepan Ian MichaelChief Financial Officer
|
Tax withholdingCommon Stock | 398 | $79.36 | $31,585.28 |
DisclosureSEC source: 0001209191-22-017347 · doc4.xml · nonDerivative · entry 2 Estepan Ian Michael · CIK 0001836254 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,671 F2 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 5, 2018. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 01:01 UTC | GrantStock Option (right to buy) · Derivative | 48,000 | $0.00 Strike: $80.42 | $0.00 |
DisclosureSEC source: 0001209191-22-017345 · doc4.xml · derivative · entry 3 Ciambrone William · CIK 0001794135 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Underlying: Common Stock · 48,000 shares Expires 2032-03-07 F4 · derivative.exercise_date: Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter. Read SEC document |
|
| March 07, 2022 Filed Mar 9, 2022 01:01 UTC | GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017345 · doc4.xml · nonDerivative · entry 2 Ciambrone William · CIK 0001794135 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,099 F3 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date. Read SEC document |
|
| March 07, 2022 Filed Mar 9, 2022 01:00 UTC |
Rodino-Klapac LouiseHead of R&D, CSO
|
GrantStock Option (right to buy) · Derivative | 48,000 | $0.00 Strike: $80.42 | $0.00 |
DisclosureSEC source: 0001209191-22-017343 · doc4.xml · derivative · entry 3 Rodino-Klapac Louise · CIK 0001836218 · Head of R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Underlying: Common Stock · 48,000 shares Expires 2032-03-07 F3 · derivative.exercise_date: Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 01:00 UTC |
Rodino-Klapac LouiseHead of R&D, CSO
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017343 · doc4.xml · nonDerivative · entry 2 Rodino-Klapac Louise · CIK 0001836218 · Head of R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,111 F2 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date. Read SEC document |
| March 07, 2022 Filed Mar 10, 2022 01:02 UTC |
Mayo StephenDirector
|
GrantStock Option (right to buy) · Derivative | 5,077 | $0.00 Strike: $80.42 | $0.00 |
DisclosureSEC source: 0001209191-22-017713 · doc4.xml · derivative · entry 2 Mayo Stephen · CIK 0001849061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,077 Underlying: Common Stock · 5,077 shares Expires 2032-03-07 Read SEC document |
| March 07, 2022 Filed Mar 10, 2022 01:02 UTC |
Mayo StephenDirector
|
GrantCommon Stock | 2,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017713 · doc4.xml · nonDerivative · entry 1 Mayo Stephen · CIK 0001849061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,245 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 7, 2023. Read SEC document |
| March 04, 2022 Filed Mar 9, 2022 01:02 UTC |
Brown Ryan EdwardSVP, General Counsel
|
Tax withholdingCommon Stock | 1,136 | $79.20 | $89,971.20 |
DisclosureSEC source: 0001209191-22-017346 · doc4.xml · nonDerivative · entry 1 Brown Ryan Edward · CIK 0001848718 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,048 F1 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021. Read SEC document |
| March 04, 2022 Filed Mar 9, 2022 01:02 UTC |
Estepan Ian MichaelChief Financial Officer
|
Tax withholdingCommon Stock | 1,308 | $79.20 | $103,593.60 |
DisclosureSEC source: 0001209191-22-017347 · doc4.xml · nonDerivative · entry 1 Estepan Ian Michael · CIK 0001836254 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,069 F1 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021. Read SEC document |
| March 04, 2022 Filed Mar 9, 2022 01:01 UTC | Tax withholdingCommon Stock | 1,160 | $79.20 | $91,872.00 |
DisclosureSEC source: 0001209191-22-017345 · doc4.xml · nonDerivative · entry 1 Ciambrone William · CIK 0001794135 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,099 F1 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021. F2 · balance_after: The amount of securities directly owned by the reporting person includes the following shares of common stock purchased under the Company's Amended and Restated 2013 Employee Stock Purchase Plan: 77 shares on February 28, 2022, 75 shares on August 31, 2021, 62 shares on February 28, 2021 and 45 shares on August 31, 2020. Read SEC document |
|
| March 04, 2022 Filed Mar 9, 2022 01:00 UTC |
Rodino-Klapac LouiseHead of R&D, CSO
|
Tax withholdingCommon Stock | 1,216 | $79.20 | $96,307.20 |
DisclosureSEC source: 0001209191-22-017343 · doc4.xml · nonDerivative · entry 1 Rodino-Klapac Louise · CIK 0001836218 · Head of R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,111 F1 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 01:03 UTC |
Rodino-Klapac LouiseHead of R&D, CSO
|
Tax withholdingCommon Stock | 572 | $75.05 | $42,928.60 |
DisclosureSEC source: 0001209191-22-014409 · doc4.xml · nonDerivative · entry 1 Rodino-Klapac Louise · CIK 0001836218 · Head of R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,327 F1 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020. F2 · balance_after: The amount of securities directly owned by the reporting person includes 221 shares of common stock purchased under the Company's Amended and Restated 2013 Employee Stock Purchase Plan on February 28, 2022. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 01:02 UTC |
Estepan Ian MichaelChief Financial Officer
|
Tax withholdingCommon Stock | 376 | $75.05 | $28,218.80 |
DisclosureSEC source: 0001209191-22-014408 · doc4.xml · nonDerivative · entry 1 Estepan Ian Michael · CIK 0001836254 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,377 F1 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 01:01 UTC |
Brown Ryan EdwardSVP, General Counsel
|
Tax withholdingCommon Stock | 184 | $75.05 | $13,809.20 |
DisclosureSEC source: 0001209191-22-014407 · doc4.xml · nonDerivative · entry 1 Brown Ryan Edward · CIK 0001848718 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,184 F1 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 01:00 UTC |
BEHRENS M KATHLEENDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $10.08 | $0.00 |
DisclosureSEC source: 0001209191-21-070084 · doc4.xml · derivative · entry 3 BEHRENS M KATHLEEN · CIK 0001211701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2022-08-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 01:00 UTC |
BEHRENS M KATHLEENDirector
|
Exercise / conversionCommon Stock | 5,000 | $10.08 | $50,400.00 |
DisclosureSEC source: 0001209191-21-070084 · doc4.xml · nonDerivative · entry 1 BEHRENS M KATHLEEN · CIK 0001211701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,517 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2021 Filed Dec 15, 2021 01:02 UTC |
GRAY MARY ANNDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 967 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-069638 · doc4.xml · derivative · entry 2 GRAY MARY ANN · CIK 0001261974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 967 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Sarepta Therapeutics, Inc. common stock. F2 · derivative.exercise_date: The third out of three annual equal installments of restricted stock units vested on December 10, 2021. F2 · derivative.expiration_date: The third out of three annual equal installments of restricted stock units vested on December 10, 2021. Read SEC document |
| December 10, 2021 Filed Dec 15, 2021 01:02 UTC |
GRAY MARY ANNDirector
|
Exercise / conversionCommon Stock | 967 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-069638 · doc4.xml · nonDerivative · entry 1 GRAY MARY ANN · CIK 0001261974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,403 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Sarepta Therapeutics, Inc. common stock. Read SEC document |
| November 24, 2021 Filed Nov 29, 2021 13:00 UTC |
Rodino-Klapac LouiseHead of R&D, CSO
|
PurchaseCommon Stock | 3,780 | $79.33 | $299,867.40 |
DisclosureSEC source: 0001209191-21-066948 · doc4.xml · nonDerivative · entry 1 Rodino-Klapac Louise · CIK 0001836218 · Head of R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,678 Read SEC document |
| November 17, 2021 Filed Nov 17, 2021 23:24 UTC |
INGRAM DOUGLAS SDirector · President & CEO
|
PurchaseCommon Stock | 25,026 | $79.94 | $2,000,578.44 |
DisclosureSEC source: 0001209191-21-065246 · doc4.xml · nonDerivative · entry 1 INGRAM DOUGLAS S · CIK 0001190644 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365,082 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $79.62 to $80.06, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| November 16, 2021 Filed Nov 18, 2021 01:06 UTC |
Mayo StephenDirector
|
GrantStock Option (right to buy) · Derivative | 8,238 | $0.00 Strike: $83.00 | $0.00 |
DisclosureSEC source: 0001209191-21-065315 · doc4.xml · derivative · entry 2 Mayo Stephen · CIK 0001849061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,238 Underlying: Common Stock · 8,238 shares Expires 2031-11-16 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning November 16, 2022. Read SEC document |
| November 16, 2021 Filed Nov 18, 2021 01:06 UTC |
Mayo StephenDirector
|
GrantCommon Stock | 4,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-065315 · doc4.xml · nonDerivative · entry 1 Mayo Stephen · CIK 0001849061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,292 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs vest in three equal annual installments beginning November 16, 2022. Read SEC document |
| November 16, 2021 Filed Nov 18, 2021 01:03 UTC |
Rodino-Klapac LouiseChief Scientific Officer
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-065314 · doc4.xml · nonDerivative · entry 1 Rodino-Klapac Louise · CIK 0001836218 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,898 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date. F2 · balance_after: The amount of securities directly owned by the reporting person includes 118 shares of common stock purchased under the Company's Amended and Restated 2013 Employee Stock Purchase Plan on August 31, 2021. Read SEC document |
| September 08, 2021 Filed Sep 10, 2021 00:00 UTC |
Estepan Ian MichaelChief Financial Officer
|
Tax withholdingCommon Stock | 1,623 | $78.29 | $127,064.67 |
DisclosureSEC source: 0001209191-21-055383 · doc4.xml · nonDerivative · entry 1 Estepan Ian Michael · CIK 0001836254 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,753 F1 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock. Read SEC document |
| June 26, 2021 Filed Jun 29, 2021 00:00 UTC |
INGRAM DOUGLAS SDirector · President & CEO
|
Tax withholdingCommon Stock | 17,812 | $80.40 | $1,432,084.80 |
DisclosureSEC source: 0001209191-21-043582 · doc4.xml · nonDerivative · entry 1 INGRAM DOUGLAS S · CIK 0001190644 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,056 F1 · kind: Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of a restricted stock award granted on June 26, 2017. F1 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of a restricted stock award granted on June 26, 2017. F1 · acquired: Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of a restricted stock award granted on June 26, 2017. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 20:57 UTC |
Brown Ryan EdwardSVP, General Counsel
|
Tax withholdingCommon Stock | 64 | $76.01 | $4,864.64 |
DisclosureSEC source: 0001209191-21-037727 · doc4.xml · nonDerivative · entry 1 Brown Ryan Edward · CIK 0001848718 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,368 F1 · kind: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on May 31, 2019. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 01:04 UTC |
BEHRENS M KATHLEENDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $42.30 | $0.00 |
DisclosureSEC source: 0001209191-21-019671 · doc4.xml · derivative · entry 4 BEHRENS M KATHLEEN · CIK 0001211701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2021-06-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 01:04 UTC |
BEHRENS M KATHLEENDirector
|
SaleCommon Stock | 5,000 | $85.76 | $428,800.00 |
DisclosureSEC source: 0001209191-21-019671 · doc4.xml · nonDerivative · entry 2 BEHRENS M KATHLEEN · CIK 0001211701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,517 Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 01:04 UTC |
BEHRENS M KATHLEENDirector
|
Exercise / conversionCommon Stock | 5,000 | $42.30 | $211,500.00 |
DisclosureSEC source: 0001209191-21-019671 · doc4.xml · nonDerivative · entry 1 BEHRENS M KATHLEEN · CIK 0001211701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,517 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:03 UTC |
Wigzell Hans Lennart RudolfDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $34.92 | $0.00 |
DisclosureSEC source: 0001209191-21-019670 · doc4.xml · derivative · entry 3 Wigzell Hans Lennart Rudolf · CIK 0001492766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2023-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:03 UTC |
Wigzell Hans Lennart RudolfDirector
|
SaleCommon Stock | 10,000 | $83.51 | $835,100.00 |
DisclosureSEC source: 0001209191-21-019670 · doc4.xml · nonDerivative · entry 2 Wigzell Hans Lennart Rudolf · CIK 0001492766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,518 F1 · price: The shares were sold in transactions at prices ranging from 83.33 to 83.91, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:03 UTC |
Wigzell Hans Lennart RudolfDirector
|
Exercise / conversionCommon Stock | 10,000 | $34.92 | $349,200.00 |
DisclosureSEC source: 0001209191-21-019670 · doc4.xml · nonDerivative · entry 1 Wigzell Hans Lennart Rudolf · CIK 0001492766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2021 Filed Mar 11, 2021 01:00 UTC Amendment |
Estepan Ian MichaelChief Financial Officer
|
Tax withholdingCommon Stock | 347 | $84.65 | $29,373.55 |
DisclosureSEC source: 0001209191-21-019664 · doc4a.xml · nonDerivative · entry 3 Estepan Ian Michael · CIK 0001836254 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,376 F3 · kind: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 5, 2018. Read SEC document |
| March 04, 2021 Filed Mar 11, 2021 01:01 UTC Amendment |
Brown Ryan EdwardSVP, General Counsel
|
Tax withholdingCommon Stock | 190 | $80.76 | $15,344.40 |
DisclosureSEC source: 0001209191-21-019667 · doc4a.xml · nonDerivative · entry 3 Brown Ryan Edward · CIK 0001848718 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,432 F3 · kind: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 4, 2019. Read SEC document |
| March 03, 2021 Filed Mar 6, 2021 01:06 UTC |
Wigzell Hans Lennart RudolfDirector
|
GrantStock Option (right to buy) · Derivative | 5,518 | $0.00 Strike: $87.11 | $0.00 |
DisclosureSEC source: 0001209191-21-018423 · doc4.xml · derivative · entry 2 Wigzell Hans Lennart Rudolf · CIK 0001492766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,518 Underlying: Common Stock · 5,518 shares Expires 2031-03-03 Read SEC document |
| March 03, 2021 Filed Mar 6, 2021 01:06 UTC |
Wigzell Hans Lennart RudolfDirector
|
GrantCommon Stock | 2,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018423 · doc4.xml · nonDerivative · entry 1 Wigzell Hans Lennart Rudolf · CIK 0001492766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,518 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 3, 2022. Read SEC document |
| March 03, 2021 Filed Mar 6, 2021 01:05 UTC |
Rodino-Klapac LouiseChief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $87.11 | $0.00 |
DisclosureSEC source: 0001209191-21-018421 · doc4.xml · derivative · entry 2 Rodino-Klapac Louise · CIK 0001836218 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2031-03-03 F2 · derivative.exercise_date: Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and becomes exercisable on each monthly anniversary thereafter. Read SEC document |
| March 03, 2021 Filed Mar 6, 2021 01:05 UTC |
Rodino-Klapac LouiseChief Scientific Officer
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018421 · doc4.xml · nonDerivative · entry 1 Rodino-Klapac Louise · CIK 0001836218 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,169 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest and become exercisable on the first anniversary of the grant date, and additional 25% will vest and become exercisable on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested and exercisable on the fourth anniversary of the grant date. Read SEC document |
| March 03, 2021 Filed Mar 6, 2021 01:05 UTC |
O'Neill Gilmore NeilEVP, R&D & CMO
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $87.11 | $0.00 |
DisclosureSEC source: 0001209191-21-018420 · doc4.xml · derivative · entry 2 O'Neill Gilmore Neil · CIK 0001742084 · EVP, R&D & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2031-03-03 F2 · derivative.exercise_date: Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter. Read SEC document |
| March 03, 2021 Filed Mar 6, 2021 01:05 UTC |
O'Neill Gilmore NeilEVP, R&D & CMO
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018420 · doc4.xml · nonDerivative · entry 1 O'Neill Gilmore Neil · CIK 0001742084 · EVP, R&D & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,070 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest and become exercisable on the first anniversary of the grant date, and additional 25% will vest and become exercisable on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested and exercisable on the fourth anniversary of the grant date. Read SEC document |
| March 03, 2021 Filed Mar 6, 2021 01:04 UTC |
Nicaise ClaudeDirector
|
GrantStock Option (right to buy) · Derivative | 5,518 | $0.00 Strike: $87.11 | $0.00 |
DisclosureSEC source: 0001209191-21-018419 · doc4.xml · derivative · entry 2 Nicaise Claude · CIK 0001644162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,518 Underlying: Common Stock · 5,518 shares Expires 2031-03-03 Read SEC document |
| March 03, 2021 Filed Mar 6, 2021 01:04 UTC |
Nicaise ClaudeDirector
|
GrantCommon Stock | 2,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018419 · doc4.xml · nonDerivative · entry 1 Nicaise Claude · CIK 0001644162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,852 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 3, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.